June 26 (Reuters) - FibroGen said on Monday its experimental drug, pamrevlumab, for treating lung disease idiopathic pulmonary fibrosis did not meet its main goal in a late-stage study. (Reporting by Raghav Mahobe in Bengaluru; Editing by Shinjini Ganguli)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Nancy Pelosi's husband Paul Pelosi uses an investing strategy that lowers upfront costs.
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
The $50 million purchase could turn into Nvidia's biggest investment.
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
“When she died, we were told by her attorney that we were responsible for the taxes and property insurance during the time when the life tennant lives in the home.”
The number probably isn't anywhere near what you think it is.